(Q43844183)
Statements
An open-label safety study of first-line bevacizumab in combination with standard chemotherapy in Chinese patients with metastatic colorectal cancer treated in an expanded access program in Taiwan (English)
Kuan-Der Lee
Hong-Hwa Chen
Hwei-Ming Wang
Chao-Jung Tsao
Tzu-Chi Hsu
Chang-Fang Chiu